相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?
Ralph Boccia et al.
ONCOLOGIST (2022)
Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review
Douglas W. Blayney et al.
CANCER TREATMENT REVIEWS (2022)
Analyzing Adherence to the 2016 Infectious Diseases Society of America Guidelines for Candidemia in Cancer Patients
Dena M. Lehmann et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Ahuva Averin et al.
SUPPORTIVE CARE IN CANCER (2021)
Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study
Prarthna V. Bhardwaj et al.
SUPPORTIVE CARE IN CANCER (2021)
Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: A systematic review and meta-analysis
Bo Zheng et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Mortality and admission to intensive care units after febrile neutropenia in patients with cancer
Theis Aagaard et al.
CANCER MEDICINE (2020)
Febrile neutropenia management in cancer patients receiving anti-cancer agents' treatment: Deepening the search to offer the best care. A critical review follow-up
Meritxell Casanovas-Blanco et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Febrile Neutropenia in Patients with Solid Tumors Undergoing Intravenous Chemotherapy
Joao Moreira-Pinto et al.
ONCOLOGY RESEARCH AND TREATMENT (2020)
Management of Patients With Fever and Neutropenia Through the Arc of Time A Narrative Review
Philip A. Pizzo
ANNALS OF INTERNAL MEDICINE (2019)
Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation
Martin Schmidt-Hieber et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2019)
Epidemiology and source of infection in patients with febrile neutropenia: A ten-year longitudinal study
Jaffar A. Al-Tawfiq et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2019)
Febrile Neutropenia: An Ounce of Prevention or a Pound of Cure
Gary H. Lyman
JOURNAL OF ONCOLOGY PRACTICE (2019)
Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia
Julia Cupp et al.
CLINICAL LUNG CANCER (2018)
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update
Randy A. Taplitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study
Bernardo Leon Rapoport et al.
BMC CANCER (2018)
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update
Randy A. Taplitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study
Nicolas Delanoy et al.
Lancet Haematology (2018)
Validation of MASCC Score for Risk Stratification in Patients of Hematological Disorders with Febrile Neutropenia
M. Taj et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2017)
Validation of MASCC Score for Risk Stratification in Patients of Hematological Disorders with Febrile Neutropenia
M. Taj et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2017)
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
J. Klastersky et al.
ANNALS OF ONCOLOGY (2016)
Risk factors for febrile neutropenia in cancer patients treated with chemotherapy
Leila Family et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Evaluation of febrile neutropenic episodes in adult patients with solid tumors
Oktay Yapici et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
Invasive Gram-Positive Bacterial Infection in Cancer Patients
Thomas Holland et al.
CLINICAL INFECTIOUS DISEASES (2014)
Advances in Prevention and Management of Central Line-Associated Bloodstream Infections in Patients With Cancer
Issam Raad et al.
CLINICAL INFECTIOUS DISEASES (2014)
Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review
Gary H. Lyman et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact
Enrico M. Trecarichi et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2014)
Clinical and microbiological profile of febrile neutropenia in solid tumors and hematological malignancies at a tertiary cancer care center in South India
L. A. Jacob et al.
INDIAN JOURNAL OF CANCER (2014)
Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings
Derek Weycker et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2014)
Bacteremia in adult cancer patients with apparently stable febrile neutropenia: data from a cohort of 692 consecutive episodes from a single institution
Alberto Carmona-Bayonas et al.
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY (2014)
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
Christopher R. Flowers et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients
Ron Ram et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Colony-Stimulating Factor Use and Impact on Febrile Neutropenia Among Patients with Newly Diagnosed Breast, Colorectal, or Non-Small Cell Lung Cancer Who Were Receiving Chemotherapy
Jeannine S. McCune et al.
PHARMACOTHERAPY (2012)
Prognostic evaluation of febrile neutropaenia in apparently stable adult cancer patients
A. Carmona-Bayonas et al.
BRITISH JOURNAL OF CANCER (2011)
Costs and outcomes associated with hospitalized cancer patients with neutropenic complications: A retrospective study
M. Blane Schilling et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2011)
A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients
Ronen Ben-Ami et al.
CLINICAL INFECTIOUS DISEASES (2009)
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
NM Kuderer et al.
CANCER (2006)
Identifying groups at high risk for carriage of antibiotic-resistant bacteria
JP Furuno et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Management of fever in neutropenic patients with different risks of complications
J Klastersky
CLINICAL INFECTIOUS DISEASES (2004)
分享论文
